We found that there were no significant differences on the RFS and DMFS between the low levels of GLDC and the high levels of GLDC in Luminal A, Luminal B and HER2 positive types of breast cancer (Figures 2G–L). This evidence concerns the gene ERBB2 and breast carcinoma.